RTW INVESTMENTS, LP - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2022$293,000
-97.8%
223,725
-97.0%
0.01%
-96.9%
Q4 2021$13,296,000
-18.1%
7,554,817
+0.9%
0.19%
-20.8%
Q3 2021$16,240,000
-36.9%
7,483,757
+1.7%
0.24%
-37.0%
Q2 2021$25,753,000
-64.5%
7,357,917
+0.1%
0.39%
-65.6%
Q1 2021$72,461,000
-7.5%
7,348,976
+1.7%
1.13%
-13.9%
Q4 2020$78,345,000
+5.1%
7,227,364
-0.1%
1.31%
-26.8%
Q3 2020$74,518,000
-47.4%
7,234,764
+6.5%
1.79%
-55.0%
Q2 2020$141,776,000
+118.8%
6,790,027
+2.4%
3.99%
+43.0%
Q1 2020$64,791,000
-11.9%
6,631,627
+3.8%
2.79%
+0.5%
Q4 2019$73,574,000
+114.9%
6,386,607
+1.7%
2.78%
+36.3%
Q3 2019$34,231,000
-54.4%
6,281,003
-0.6%
2.04%
-49.3%
Q2 2019$75,149,000
+129.2%
6,320,350
+1.0%
4.01%
+79.4%
Q1 2019$32,786,000
+66.4%
6,256,8400.0%2.24%
+22.0%
Q4 2018$19,709,000
+1662.9%
6,256,840
+3285.4%
1.83%
+2637.3%
Q3 2018$1,118,000
+19.6%
184,821
+4.8%
0.07%0.0%
Q2 2018$935,000
-8.0%
176,372
+0.7%
0.07%
-30.9%
Q1 2018$1,016,000175,2080.10%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders